A review on the permissible use of Bacchus-S as another tradename of quasi-drug, which is similar to Bacchus-F drink as a prescription drug, has been underway, according to the Korea Food and Drug Administration.
Dong-A has filed its application to the regional KFDA in the tradename of Bacchus-S as a quasi-drug by changing some ingredients of Bacchus-F.
In response, the KFDA at headquart...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.